Current and Future Biomarkers in Esophagogastric Adenocarcinoma

ConclusionOngoing efforts to identify novel biomarkers in EGA have led to enhanced subclassification of upper GI cancers. These advances, coupled with the strategic application of targeted therapies and immunotherapy when appropriate, hold promise to further improve patients outcomes.
Source: Journal of Gastrointestinal Cancer - Category: Cancer & Oncology Source Type: research